Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
A completed Travera Inc trial evaluating TraveraRTGx and a tumor-cell biomarker intended to guide rapid therapy decisions across multiple ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update reports that Imunon is conducting Phase 1/Phase 2 study IMNN-001 (GEN-1) in newly diagnosed advanced ovarian, fal…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer [Phase 1]
Phase 1 clinical trial assessing different dosing amounts of the drug combination M1774 and ZEN-3694 for recurrent ovarian and endometrial c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers [Phase 1]
This is a Phase 1 clinical trial update evaluating the combination of APG-1252 (Pelcitoclax) and cobimetinib in recurrent and advanced ovari…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma [Phase 1]
Phase 1 clinical trial update on QXL138AM assessing safety, pharmacokinetics, and preliminary efficacy in patients with solid tumors and mul…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
A completed clinical trial update evaluating niraparib in patients with ovarian cancer in routine clinical practice.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
This clinical trial registry entry describes a study evaluating treatments for chemotherapy-induced peripheral neuropathy in cancer patients…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer [Phase 3]
A Phase 3 clinical trial evaluating IMNN-001 in combination with standard neoadjuvant and adjuvant chemotherapy for newly diagnosed advanced…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) [Phase 2]
This Phase 2 MATCH Screening Trial update describes ongoing evaluation of targeted therapies matched to genetic alterations in patients with…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]
This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the combination of ZEN003694 with nivolumab, with or without ipilimumab, in metastatic and recurrent solid…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating ONC-392 in combination with pembrolizumab for platinum-resistant ovarian cancer is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib [Phase 2]
This Clinical Trial Update reports a Phase 2 study evaluating maintenance therapy with the antibody-drug conjugate mirvetuximab soravtansine…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors [NA]
A ClinicalTrials.gov update for REVITALIZE, a randomized trial to reduce fatigue in adults with ovarian cancer on PARP inhibitors; the study…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy [Phase 2]
Phase 2 clinical trial update comparing sacituzumab govitecan with bevacizumab to standard chemotherapy for recurrent platinum-sensitive ova…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors [Phase 2]
A Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-expressing tumors, including bladder, biliary tract, cervical, …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: The Registry of Genetic Alterations of Taiwan Ovarian Cancer
A Taiwan registry study collecting genetic alterations in ovarian cancer patients, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
Updates on the SENTRY study investigating platelet RNA changes to improve early diagnosis of ovarian cancer; the trial is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Study of Intra-operative Imaging in Women With Ovarian Cancer [Phase 3]
A Phase 3 study evaluating intra-operative imaging in women with ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor [NA]
Apatinib plus letrozole, with or without fluzoparib, are being studied for estrogen receptor-positive, platinum-sensitive recurrent ovarian …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence [Phase 2]
This entry describes a Phase 2 clinical trial of an IGFBP-2 vaccine to prevent ovarian cancer progression in patients with serologic evidenc…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…